Representative Schematic of a Potential Trial Design (IMAGE)

Deep Longevity Ltd

Representative Schematic of a Potential Trial Design

Caption

randomized clinical trial for prevention of COVID-19 by rapamycin would likely involve transient rapamycin treatment with rapamycin in older (selectively enrolled if estimated biological age exceeds their chronological age) adults at high risk for COVID-19 complications over a period of several weeks.

Credit

Deep Longevity Limited

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.